- •Dedication
- •Preface
- •Acknowledgements
- •Contributors
- •Contents
- •1. Minimally Invasive Oculoplastic Surgery
- •1.1 General Points
- •1.2 Lower Lid Entropion
- •1.2.1 Introduction
- •1.2.2 Lower Lid Entropion Sutures
- •1.2.3 Lower Lid Entropion Botulinum Toxin
- •1.3 Lower Lid Ectropion
- •1.3.1 Introduction
- •1.3.2 The Royce Johnson Suture
- •1.3.3 The Pillar Tarsorrhaphy
- •1.4 Distichiasis
- •1.4.1 Introduction
- •1.4.2 Direct Excision of Lashes
- •1.5 Ptosis
- •1.5.1 Introduction
- •1.5.3 Anterior Approach – One Stitch Aponeurosis Repair
- •1.5.4 Supramid Brow Suspension
- •1.6 Lid Retraction
- •1.6.1 Introduction
- •1.6.2 Koornneef Blepharotomy
- •1.6.3 Botulinum Toxin
- •1.7 Lid Tumours
- •1.7.1 Mohs’ Micrographic Surgery
- •1.7.2 Lamella Sparing Tumour Excision
- •References
- •2. Minimally Invasive Conjunctival Surgery
- •2.1 Conjunctival Surgery
- •2.2 Conjunctivochalasis
- •2.2.1 Background of the Disease
- •2.2.2 Indication for Surgery
- •2.2.3 Basic Concept of Surgery
- •2.2.4 Surgical Procedure
- •2.2.5 Postoperative Follow-Up
- •2.3 Pterygium
- •2.3.1 Background of the Disease and the Concept of Minimally Invasive Surgery
- •2.3.2 Indication for Surgery
- •2.3.3 Basic Concept of Surgery
- •2.3.4 Surgical Procedures
- •2.3.5 A Biologic Adhesive for Sutureless Pterygium Surgery
- •2.3.6 Postoperative Follow-Up
- •2.4 Limbal and Conjuntival Dermoids
- •2.4.1 Background of the Disease
- •2.4.2 Basic Concept of Surgery
- •2.4.3 Surgical Procedure
- •2.4.4 Postoperative Follow-Up
- •2.5 Strabismus Surgery
- •2.6 Conclusion
- •References
- •3. Minimally Invasive Lacrimal Surgery
- •3.1 Introduction
- •3.1.1 Causes of Stenoses of the Lacrimal Drainage System
- •3.1.3 General Remarks Regarding Surgical Management
- •3.2 Endonasal Endoscopic (Microscopic) Dacryocystorhinostomy (EDCR)
- •3.2.1 Indication for EDCR
- •3.2.2 Surgical Technique
- •3.2.3 Silicone Stenting for EDCR
- •3.2.2.1 Silicone “Cones” (Lacrimal Duct Stent, Bess, Berlin)
- •3.2.4 Use of Mitomycin C for EDCR
- •3.2.5 Post-Operative Care After EDCR
- •3.2.6 Results of EDCR
- •3.3 Endonasal Endoscopic Laser Dacryocystorhinostomy (ELDCR)
- •3.3.1 Indications for ELDCR
- •3.3.2 Contraindications for ELDCR
- •3.3.3 Surgical Technique for ELDCR
- •3.3.4 Potential Problems with ELDCR
- •3.3.5 Post-Operative Care After ELDCR
- •3.3.6 Results of ELDCR
- •3.4 Dacryoendoscopy with Transcanalicular Laserdacryoplasty (TLDP)
- •3.4.1 Indication for TLDP
- •3.4.2 Contraindication for TLDP
- •3.4.3 Surgical Technique for TLDP
- •3.4.4 Results of TLDP
- •3.5 Microdrill Dacryoplasty (MDP)
- •3.5.1 Indication for MDP
- •3.5.2 Contraindication for MDP
- •3.5.3 MDP Procedure
- •3.5.4 Results of MDP
- •3.6 Balloon Dilatation
- •3.6.1 Indications for Balloon Dilatation
- •3.6.2 Anaesthesia for Balloon Dilatation
- •3.6.3 Surgical Technique with 2 mm or 3 mm Balloon for Incomplete Stenosis
- •3.6.3.1 Post-Operative Care
- •3.6.3.2 Complications
- •3.6.3.3 Results
- •3.6.4.1 Post-Operative Care
- •3.6.4.2 Results
- •3.6.4.3 Complications
- •3.7 Stent Placement
- •3.7.1 Indications for Stent Placement
- •3.7.3 Surgical Technique for Stent Placement
- •3.7.5 Results of Stent Placement
- •References
- •4. Minimally Invasive Corneal Surgery
- •4.1 Penetrating Keratoplasty
- •4.1.1 Introduction
- •4.1.2 Indications
- •4.1.3 Preoperative Evaluation of the Keratoplasty Patient
- •4.1.4 Preparation for Penetrating Keratoplasty
- •4.1.4.1 Eyelid Speculum
- •4.1.4.2 Scleral Fixation Rings
- •4.1.4.3 Large and Fine-Tipped Needle Holder
- •4.1.4.4 Toothed Forceps
- •4.1.4.5 Trephine Blades
- •4.1.4.6 Radial Marker
- •4.1.4.7 Cornea Punch
- •4.1.4.8 Cutting Block
- •4.1.4.9 Scissors
- •4.1.4.10 Cannulas and Blades
- •4.1.5 Preoperative Medications
- •4.1.6 Penetrating Keratoplasty Surgical Procedure
- •4.1.6.1 Placement of the Scleral Fixation Ring
- •4.1.6.2 Marking of the Host Cornea
- •4.1.6.3 Sizing of the Trephine
- •4.1.6.4 Trephination of the Host Cornea
- •4.1.6.5 Trephination of the Donor Cornea
- •4.1.6.6 Removal of the Host Cornea
- •4.1.6.7 Placement of the Donor Cornea Tissue in the Host Stromal Bed
- •4.1.6.8 Placement of the Cardinal Sutures
- •4.1.6.9 Completion of Suturing
- •4.1.6.10 Suture Techniques
- •4.1.6.11 Subconjunctival Medications
- •4.1.7 Intraoperative Complications
- •4.1.7.1 Scleral Perforation
- •4.1.7.2 Damage to the Donor Button
- •4.1.7.4 Posterior Capsule Rupture
- •4.1.7.5 Vitreous Loss
- •4.1.7.6 Anterior Chamber Hemorrhage
- •4.1.7.7 Choroidal Hemorrhage
- •4.1.8 Postoperative Management
- •4.1.8.1 Postoperative Immunosuppressive Regimen
- •4.1.9 Postoperative Complications
- •4.1.9.1 Wound Leaks
- •4.1.9.2 Epithelial Defects
- •4.1.9.3 Suture-Related Problems
- •4.1.9.4 Increased Intraocular Pressure
- •4.1.9.5 Post-Keratoplasty Astigmatism
- •4.1.10.1 Wedge Resections and Compression Sutures
- •4.1.10.2 Relaxing Incisions
- •4.1.10.3 LASIK
- •4.1.10.4 Photorefractive Keratectomy with Mitomycin C
- •4.1.11 Corneal Allograft Rejection
- •4.1.11.1 Host Risk Factors
- •4.1.11.2 Vascularized Corneas
- •4.1.11.3 Prior Graft Loss
- •4.1.11.4 Graft Diameter
- •4.1.11.5 Anterior Synechiae
- •4.1.11.6 Previous Intraocular Surgery
- •4.1.11.7 Herpes Simplex
- •4.1.12 Treatment of Allograft Rejection
- •4.1.13 Large Diameter Penetrating Keratoplasty
- •4.1.14 Summary
- •References
- •4.2 Descemet’s Stripping Endothelial Keratoplasty
- •4.2.1 Introduction
- •4.2.2 Descemet’s Stripping Endothelial Keratoplasty Surgical Technique
- •4.2.2.1 Donor Cornea Preparation
- •4.2.2.2 Host Cornea Preparation
- •4.2.2.3 Insertion of the Donor Cornea
- •4.2.3 Postoperative Medications
- •4.2.4 Donor Dislocation Risks
- •4.2.5 Repositioning Donor Tissue
- •4.2.6 Treatment of Rejection Episodes
- •4.2.7 Visual and Refractive Outcomes
- •4.2.8 Other Complications
- •4.2.9 Summary
- •References
- •4.3 Pterygium
- •4.3.1 Introduction
- •4.3.2 Treatment of Pterygium
- •4.3.3 Surgical Technique
- •4.3.3.1 Removal of the Pterygium
- •4.3.3.2 Harvesting the Conjunctival Autograft
- •4.3.3.3 Securing the Conjunctival Autograft
- •4.3.3.4 Fibrin Glue vs. Nylon Sutures
- •4.3.4 Postoperative Management
- •4.3.5 Recurrent Pterygium
- •4.3.6 Other Techniques in Pterygium Removal
- •4.3.6.1 Bare Scleral Technique
- •4.3.6.2 Adjunctive Agents
- •Mitomycin C
- •Beta-Irradiation
- •4.3.6.3 Amniotic Membrane Transplantation
- •4.3.7 Complications in Pterygium Removal
- •4.3.8 Summary
- •References
- •5. Minimally Invasive Refractive Surgery
- •5.1 Trends in Refractive Surgery
- •5.2 Introduction
- •5.3 Cornea Refractive Surgery
- •5.3.1 Laser In Situ Keratomileusis (LASIK)
- •5.3.1.1 Advances in Flap Creation Technology
- •Microkeratomes
- •Femtosecond Laser
- •5.3.1.2 Technological Advances in Laser Delivery Platforms
- •5.3.1.3 Faster Excimer Lasers
- •5.3.1.4 Reduction of Collateral Thermal Tissue Damage
- •5.3.1.5 Advanced Eye Trackers
- •5.3.2 PRK and Advanced Surface Ablations (ASA)
- •5.3.2.1 Decrease Thermal Load on the Cornea
- •5.3.2.2 Use of Wound-Healing Modulators
- •5.3.2.3 Trend Towards EPI-LASIK
- •5.3.3 Summary
- •5.4 Intraocular Refractive Surgery
- •5.4.1 Phakic Intraocular Lens Surgery
- •5.4.1.1 Advances in Diagnostic Equipment
- •5.4.1.2 Types of Phakic Intraocular Lens
- •5.4.1.3 Kelman-Duet Phakic Intraocular Lens
- •Lens Design
- •Surgical Technique
- •Pre-Operative Preparation
- •Operative Procedure
- •Post-Operative Care
- •Results
- •Refractive Outcomes
- •Corneal Endothelium
- •5.4.1.4 Visian Implantable Collamer Lens
- •Lens Design
- •Surgical Technique
- •Pre-Operative Preparation
- •Operative Procedure
- •Post-Operative Care
- •5.4.1.5 Results
- •5.4.2 Summary
- •5.5 Lens and Cataract Surgery
- •5.5.2 The Ideal MICS Intraocular Lens
- •5.5.2.1 Aspheric Intraocular Lenses
- •5.5.2.2 Toric Intraocular Lenses
- •5.5.2.3 ACRI.LISA 366D and ACRI.LISA TORIC 466TD
- •Lens Design
- •5.5.2.4 Surgical Technique
- •Operative Procedure
- •Post-Operative Care
- •5.5.2.5 Results
- •5.5.3 Summary
- •5.6 The Future: Beyond the Horizon of Refractive Surgery Today
- •Reference
- •6. Minimally Invasive Strabismus Surgery
- •6.1 Introduction
- •6.2 Nonsurgical Treatment
- •6.4 Rectus Muscle Procedures
- •6.4.1 MISS Rectus Muscle Recession
- •6.4.2 MISS Rectus Muscle Plication
- •6.4.3 Parks’ Rectus Muscle Recession
- •6.4.4 Parks’ Rectus Muscle Plication
- •6.4.5 MISS Rectus Muscle Posterior Fixation Suture
- •6.4.7 MISS Rectus Muscle Repeat Surgery
- •6.4.8 MISS Rectus Muscle Transposition Surgery
- •6.5 Oblique Muscle Procedures
- •6.5.1 MISS Inferior Oblique Muscle Recession
- •6.5.2 MISS Inferior Oblique Muscle Plication
- •6.5.3 MISS Superior Oblique Muscle Recession
- •6.5.4 MISS Superior Oblique Muscle Plication
- •6.5.6 Mühlendyck’s Partial Posterior Superior Oblique Tenectomy for Congenital Brown’s Syndrome
- •6.6 Postoperative Handling
- •6.7.1 Intraoperative Complications
- •6.7.2 Postoperative Complications
- •6.8 Suggestions on How to Start Doing MISS
- •6.8.1 Instruments Suitable for MISS
- •6.8.2 Suture Materials Used for MISS
- •6.8.3 General Remarks Regarding MISS Procedures
- •6.8.4 MISS Dose–Response Relationships
- •References
- •7. Minimally Invasive Iris Surgery
- •7.1 Instrumentation
- •7.2 Sutures
- •7.3 Surgical Principles of Iris Suturing
- •7.3.1 Mobilization
- •7.3.2 Intraocular Suturing and Knot Tying
- •7.3.3 Reattachment of Iris to Sclera
- •7.3.4 Pupil Repair
- •7.3.5 Adjunctive Pupil Repair Techniques
- •References
- •8. Minimally Invasive Glaucoma Surgery
- •Introduction
- •8.1.1 Introduction to Deep Sclerectomy
- •8.1.2 Anesthesia
- •8.1.3 Surgical Technique
- •8.1.3.1 Preparation
- •8.1.3.3 Deep Flap Preparation
- •8.1.3.5 Peeling of Schlemm’s Canal and Juxtacanalicular Meshwork
- •8.1.3.6 Drainage Device
- •8.1.3.7 Wound Closure
- •8.1.4 Postoperative Management and Medication
- •8.1.4.1 Medication
- •8.1.4.2 Management
- •8.1.5 Adjunctive Treatments
- •8.1.5.1 Bleb Needling
- •8.1.5.2 Nd:YAG Goniopuncture
- •8.1.6 Complications and Management
- •8.1.6.1 General
- •8.1.6.2 Perioperative Complications
- •8.1.6.3 Early Postoperative Complications
- •8.1.6.4 Late Postoperative Complications
- •Open-Angle Glaucoma
- •Pigmentary Glaucoma
- •Pseudoexfoliation Glaucoma
- •Aphakic Glaucoma
- •Sturge–Weber Syndrome
- •Glaucoma Secondary to Uveitis
- •Congenital and Juvenile Glaucoma
- •Narrow-Angle Glaucoma
- •Posttrauma Angle-Recession Glaucoma
- •Neovascular Glaucoma
- •Narrow-Angle Glaucoma in a Young Patient
- •Pseudophakic Glaucoma with an A/C IOL
- •8.2.1.4 Preoperative Considerations
- •8.2.2 Anesthesia
- •8.2.4 Postoperative Management and Medication
- •8.2.5 Outcomes and Comparison with Other Techniques
- •8.2.6 Complications and Management
- •8.2.6.1 General
- •8.2.6.4 Summary and Key Points
- •References
- •8.3 New Minimally Invasive, Sclerothalamotomy Ab Interno Surgical Technique
- •8.3.1 Introduction to the Sclerothalamotomy Ab Interno
- •8.3.1.1 Indications for the Sclerothalamotomy Ab Interno
- •8.3.2 Anesthesia
- •8.3.3 Surgical Technique
- •8.3.3.1 Preparation
- •8.3.3.2 Diathermy Probe Insertion
- •8.3.4 Postoperative Management and Medication
- •8.3.5 Outcomes and Comparison with Other Techniques
- •8.3.6 Complications and Management
- •8.3.6.1 General
- •8.3.6.3 Conclusions
- •References
- •Type of Glaucoma
- •Stage of Glaucoma
- •Combined Surgery
- •8.4.2 Anesthesia
- •8.4.3 Surgical Technique
- •8.4.3.1 Preparation
- •8.4.3.2 Implantation of the Micro-Bypass Stent
- •8.4.4 Postoperative Management and Medication
- •8.4.5 Outcomes and Combination with Other Techniques
- •8.4.5.1 Trabecular Implant in Refractory Glaucoma Patients
- •8.4.6 Conclusions
- •References
- •9. Minimally Invasive Cataract Surgery
- •10. Minimally Invasive Vitreoretinal Surgery
- •10.1 Introduction
- •10.2 Microincision Vitrectomy
- •10.2.1 Models of Wound Architecture
- •10.2.2 Vitrectomy
- •10.2.3 Adjuncts
- •10.2.4 Common Surgical Techniques
- •10.2.4.1 Macular Surgery
- •10.2.4.2 Proliferative Diabetic Retinopathy
- •10.2.4.3 Retinal Detachment
- •10.2.4.4 Pediatric Vitreoretinal Surgery
- •10.2.5 Complications
- •10.2.6 Future Developments in Minimally Invasive Vitrectomy
- •10.3 Endoscopic Vitreoretinal Surgery
- •10.3.1 Introduction
- •10.3.2 History and Development of Endoscopic Ophthalmic Surgery
- •10.3.3 The Endoscope
- •10.3.4 Applications of Intraocular Endoscopy
- •10.3.4.1 Media Opacity
- •10.3.4.3 PVR and Subretinal Surgery
- •10.3.4.4 Retained Lens Fragments
- •10.3.4.5 Anterior and Retrolental Vitrectomy in Malignant Glaucoma
- •10.3.4.5 Sutured IOL and ECP
- •10.3.5 Limitations and Challenges
- •10.4 Future Directions of Minimally Invasive Vitreoretinal Surgery
- •References
- •INDEX
1 Minimally Invasive Oculoplastic Surgery |
19 |
a |
b |
Fig. 1.21 Lamella sparing tumour excision. (a) Anterior lamella removed only; (b) raw area left to granulate
days and the patient is prescribed topical antibiotics in the usual manner (drops to the eye by day and ointment at night).
References
1.Anderson RL, Gordy DD (1979) The tarsal strip procedure. Arch Ophthalmol 97:219–226
2.Anderson RL, Harvey JT (1981) Lid splitting and posterior lamellar cryosurgery for congenital and acquired distichiasis. Arch Ophthalmol 99:631–634
3.Arnon S, Schechter R, Inglesby TV (2001) Botulinum toxin as a biological weapon. JAMA 285:1059–1070
4.Barlow RJ, Ramnarain N, Smith NP, et al (1996) Excision of selected skin tumours using Mohs’ micrographic surgery with horizontal paraffin-embedded sections. Br J Dermatol 135:911–917
5.Bartley GB (2004) Mohs surgery: proclamation, proof, principles, and promise. Ophthalmology 111:615–616
6.Bashour M, Harvey J (2000) Causes of involutional ectropion and entropion-age related tarsal changes are the key. Ophthal Plast Reconstr Surg 16:131–141
7.Beaconsfield M, Ectropion (2001) In: Collin R, Rose G (eds) Fundamentals of clinical ophthalmology: plastic and orbital surgery. BMJ Books, London
8.Beard C (1976) Ptosis. Mosby, St Louis
9.Beard CH (1914) Ophthalmic surgery, 2nd edn. Blakiston Co, Philadelphia
10.Ben Simon GJ, Lee S, Schwarcz RM et al (2005) External
levator advancement vs Muller’s muscle-conjunctival resection for correction of upper lid involutional ptosis. Am
J phthalmol 140:426–432
11.Benger RS, Musch DC (1989) A comparative study of eyelid parameters in involutional entropion. Ophthalmic Plast Reconstr Surg 5:281–287
12.Bentsianov B, Zalvan C, Blitzer A (2004) Noncosmetic uses of botulinum toxin. Clin Dermatol 22:82–88
13.Bick MW (1966) Surgical management of orbital tarsal disparity. Arch Ophthalmol 75:386–389
14.Burg G, Hirsch RD, Konz B, et al (1975) Histographic surgery: accuracy of visual assessment of the margins of basalcell epithelioma. J Dermatol Surg 1:21–24
15.Carruthers J, Carruthers A (2004) Botox: beyond wrinkles. Clin Dermatol 22:89–93
16.Carter SR, Meecham WJ, Seiff SR (1996) Silicone frontalis slings for the correction of blepharoptosis: indications and efficacy. Ophthalmology 103:623–630
17.Clarke JR, Spalton DJ (1988) Treatment of senile entropion with botulinum toxin. Br J Ophthalmol 72:361–362
18.Collin JR, O’Donnell BA (1994) Adjustable sutures in eyelid surgery for ptosis and lid retraction. Br J Ophthalmol 78:167–174
19.Collin JRO (2006) A manual of systematic eyelid surgery, 3rd edn. Elsevier, Amsterdam
20.Collin JRO, Rathbun JE (1978) Involutional entropion – a review with evaluation of a procedure. Arch Ophthalmol 96:1883–1885
21.Costa PG, Saraiva FP, Pereira IC et al (2008) Comparative study of Botox (R) injection for upper eyelid retraction with 6-month follow up in patients with thyroid eye disease in the congestive or fibrotic stage. Eye advance online publication;doi:10.1038/eye.2008.165
22.Crawford GJ, Collin JR, Moriarty PA (1984) The correction of paralytic ectropion. Br J Ophthalmol 68:639–641
23.Crawford JS (1956) Repair of ptosis using frontalis muscle and fascia lata. Trans Am Acad Ophthalmol Otolayngol 60:672–678
24.Dolly JO, Black J, Williams RS et al (1984) Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalisation. Nature 307:457–460
25.Dortzbach RK, Butera RT (1978) Excision of distichiasis lashes through a tarsoconjunctival trapdoor. Arch Ophthalmol 96:111–112
26.Downes RN, Collin JR (1990) The Mersilene mesh ptosis sling. Eye 4:456–463
20 |
M. Beaconsfield and R. Collin |
27.Doxanas MT, Dryden RM (1981) The use of sclera in the treatment of dysthyroid eyelid retraction. Ophthalmology 88:887–894
28.Elner VM, Hassan AS, Frueh BR (2003) Graded full thickness anterior blepharotomy for upper eyelid retraction. Trans Am Ophthalmol Soc 101:67–73
29.Elston JR, Russel RWR (1985) Effect of treatment with
botulinum toxin on neurogenic blepharospasm. Br Med
J 290:1857–1859
30.Ettl A (2005) Koornneef’s graded upper lid lengthening in Graves disease. Arch Ophthalmol 123:871–872
31.Foran P, Mohammed N, Lisk GO et al (2002) Evaluation of the therapeutic usefulness of botulinum neurotoxin. J Biol Ch 278:1363–1371
32.Fox SA (1960) Marginal (tarsal) ectropion. Arch Ophthalmol 63:660–662
33.Frueh BR, Mush DC, McDonald HM (2004) Efficacy and efficiency of a small incision, minimal dissection procedure vs a traditional approach for correction of aponeurotic ptosis. Ophthalmology 111:2158–2163
34.Grove AS Jr (1980) Eyelid retraction treated by levator myotomy. Ophthalmology 87:1013–1018
35.Harvey JT, Anderson RL (1981) The aponeurotic approach to eyelid retraction. Ophthalmology 88:513–524
36.Henderson JW (1965) Relief of eyelid retraction: a surgical procedure. Arch Ophthalmol 74:205–216
37.Hintschich C, Haritoglou C (2005) Full thickness eyelid transaction for upper eyelid lengthening in lid retraction associated with Graves’ disease. Br J Ophthalmol 89: 413–416
38.Jones LT (1960) The anatomy of the lower eyelid and its relation to the cause and cure of entropion. Am J Ophthalmol 49:29–36
39.Jordan DR, Anderson RL, Thiese SM (1990) The medial tarsal strip. Arch Ophthalmol 108:120–124
40.Katowitz JA (1979) Frontalis suspension in congenital ptosis using a polyfilament, cable type suture. Arch Ophthalmol 97:1659–1663
41.Kemp EG, MacAndie K (2001) Mersilene mesh as an alternative to autogenous fascia lata brow suspension. Ophthal Plast Reconstr Surg 17: 419–422
42.Kirkness CM, Adams GGW, Dilley PN et al (1988) Botulinum toxin A induced protective ptosis in corneal disease. Ophthalmology 95:473–480
43.Lee V, Currie Z, Collin JR (2004) Ophthalmic management of facial nerve palsy. Eye 18:1225–1234
44.Leone CR Jr, Shore JW, Van Gemert JV (1981) Silicone rod frontalis sling for the correction of blepharoptosis. Ophthalmic Surg 12:881–887
45.Lucarelli MJ, Lemke BN (1999) Small incision external levator repair. Am J Ophthalmol 127:637–644
46.Malhotra R, Huilgol SC, Huynh NT et al (2004) The Australian Mohs databse: periocular squamous cell carcinoma. Ophthalmology 111:617–623
47.Malhotra R, Huilgol SC, Huynh NT et al (2004) The Australian Mohs database, part 2: periocular basal cell carcinoma outcome at 5-years follow-up. Ophthalmology 111:631–636
48.Malhotra R, Huilgol SC, Huynh NT et al (2004) The Australian Mohs database, part 1: periocular basal cell carcinoma experience over 7 years. Ophthalmology 111:624–630
49.Manners RM, Tyers AG, Morris RJ (1994) The use of prolene as a temporary suspension material for brow suspension in young children. Eye 8:346–348
50.Mohs FE (1948) Chemosurgical treatment of cancer of the eyelid; a microscopically controlled method of excision. Arch Ophthalmol 39:43–59
51.Mohs FE (1941) Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg 42:279–295
52.Mourits MP, Koornneef L (1991) Lid lengthening by sclera interposition for eyelid retraction in Graves’ opthalmopathy. Br J Ophthalmol 75:344–347
53.Mourits MP, Sasim IV (1999) A single technique to correct various degrees of upper lid retraction in patients with Graves’ orbitopathy.Br J Ophthalmol 83:81–84
54.Nowinski TS, Anderson RL (1985) The medial spindle procedure for involutional ectropion. Arch Ophthalmol 103: 1750–1753
55.O’Donnell BA, Collin JR (1993) Distichiasis: management with cryotherapy to the posterior lamella. Br J Ophthalmol 77:289–292
56.Pamphlett R (1989) Early and terminal nodal sprouting of motor axons after cotulinum toxin. J Neurol Sc 92: 181–192
57.Peart DA, Hill JC (1986) Cryosurgery for trichiasis in black patients. Br J Ophthalmol 70:712–714
58.Putterman AM (1978) Ectropion of the lower lid secondary to Muller’s muscle-capsulopalpebral fascia detachment. Am J Ophthalmol 85:814–817
59.Putterman AM, Urist M (1972) Surgical treatment of upper eyelid retraction. Arch Ophthalmol 87:401–405
60.Putterman AM, Urist MJ (1975) Muller’s muscle – conjunctival resection. Arch Ophthalmol 93:619–623
61.Quickert MH, Rathbun E (1971) Suture repair of entropion. Arch Ophthalmol 85:304–305
62.Scott AB (1980) Botulinum toxin A injections into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044–1049
63.Scott AB, Rosenbaum A, Collins CC (1973) Pharmacological weakening of external ocular muscles. Invest Ophthalmol Vis Sci 12:924–927
64.Sharma TK, Willshaw H (2003) Long term follow up of ptosis correction using Mersilene mesh. Eye 17:759–761
65.Shorr N, Seiff SR (1986) The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy. Ophthalmology 93:476–483
66.Smith BC (1976) ‘Lazy-T’ operation for the correction of ectropion. Arch Ophthalmol 90:1149–1150
67.Steel DA, Hoh HB, Harrad RA et al (1997) Botulinum toxin for the temporary treatment of involutional entropion. Eye 11:472–475
68.Stefanyszyn MA, Hidayat AA, Flanagan JC (1985) The histopathology of involutional ectropion. Ophthalmology 92:120–127
69.Sullivan TJ, Collin JR (1991) Medical canthal resection: an effective long-term cure for medial ectropion. Br J Ophthalmol 75:288–291
70.Tromovitch TA, Stegman SJ (1978) Microscopic-controlled excision of cutaneous tumors: chemosurgery, fresh tissue technique. Cancer 41:653–658
1 Minimally Invasive Oculoplastic Surgery |
21 |
71.Tse DT, Kronish JW, Buus D (1991) Surgical correction of lower eyelid tarsal ectropion by re-insertion of the retractors. Arch Ophthalmol 109:427–431
72.Tucker SM, Collin R (1995) Repair of upper eyelid retraction: a comparison between adjustable and non-adjustable sutures. Br J Ophthalmol 79:658–660
73.Uddin JM, Davies PD (2002) Treatment of upper eyelid retraction associated with thyroid eye disease with
subconjunctival botulinum toxin injection. Ophthalmology 109:1183–1187
74.Vaughn GL, Dortzbach RK, Sires BS et al (1997) Eyelid splitting with excision or micro hyfrecation for distichiasis. Arch Ophthalmol 115:282–284
75.Welch ML, Anderson LL, Grabski WJ (1996) How many non-melanoma skin cancers require Mohs micrographic surgery? Dermatol Surg 22:711–713
